Bharat Biotech says its trial of Covaxin booster... ... Coronavirus Omicron in India News Highlights 8 January 2022: Telangana reports 2606 new coronavirus cases

Bharat Biotech says its trial of Covaxin booster jabs has demonstrated "long-term safety with no serious adverse events"

"90% of recipients had a detectable neutralizing antibody response against the wild-type strain (6 months after the second dose)," the Covaxin maker says